These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 24930687)

  • 1. Anxiety disorders: does one treatment fit all?
    Baldwin D
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():31-5. PubMed ID: 24930687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiety and depression: individual entities or two sides of the same coin?
    Nutt D
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():19-24. PubMed ID: 24930685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety disorders: under-diagnosed and insufficiently treated.
    Kasper S
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():3-9. PubMed ID: 24931537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based treatment of anxiety disorders.
    Stein DJ
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():16-21. PubMed ID: 24931539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Web-based screening instrument for depression and anxiety disorders in primary care.
    Farvolden P; McBride C; Bagby RM; Ravitz P
    J Med Internet Res; 2003; 5(3):e23. PubMed ID: 14517114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram in the treatment of generalized anxiety disorder.
    Baldwin DS; Nair RV
    Expert Rev Neurother; 2005 Jul; 5(4):443-9. PubMed ID: 16026227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions.
    Stein DJ; Kasper S; Andersen EW; Nil R; Lader M
    Depress Anxiety; 2004; 20(4):175-81. PubMed ID: 15643634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database.
    Baldwin DS; Stein DJ; Dolberg OT; Bandelow B
    Hum Psychopharmacol; 2009 Jun; 24(4):269-75. PubMed ID: 19334042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized anxiety disorder: how to treat, and for how long?
    Lam RW
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():10-5. PubMed ID: 24931538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue in female patients with major depression: the effect of comorbid anxiety disorders.
    Ferentinos P; Kontaxakis VP; Havaki-Kontaxaki BJ; Dikeos D; Papadimitriou GN; Lykouras L
    Psychiatriki; 2011; 22(4):320-9. PubMed ID: 22271845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized anxiety disorder: prevalence, burden, and cost to society.
    Wittchen HU
    Depress Anxiety; 2002; 16(4):162-71. PubMed ID: 12497648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological worry, anxiety disorders and the impact of co-occurrence with depressive and other anxiety disorders.
    Starcevic V; Berle D; Milicevic D; Hannan A; Lamplugh C; Eslick GD
    J Anxiety Disord; 2007; 21(8):1016-27. PubMed ID: 17270391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rethink the panic disorder].
    Amami O; Aloulou J; Siala M; Aribi L
    Encephale; 2010 Apr; 36(2):100-4. PubMed ID: 20434625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram for the treatment of major depression and anxiety disorders.
    Höschl C; Svestka J
    Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid depression and anxiety spectrum disorders.
    Gorman JM
    Depress Anxiety; 1996-1997; 4(4):160-8. PubMed ID: 9166648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond generalized anxiety disorder: psychometric properties of the GAD-7 in a heterogeneous psychiatric sample.
    Beard C; Björgvinsson T
    J Anxiety Disord; 2014 Aug; 28(6):547-52. PubMed ID: 24983795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease.
    Celano CM; Suarez L; Mastromauro C; Januzzi JL; Huffman JC
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):498-504. PubMed ID: 23759474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.